
Donaldson Co Inc Boosts Sales 2.9% with Life Sciences Surge
Donaldson Company, Inc.Description
What this story covers
Donaldson Company Inc. reported $3.7B in FY2025 net sales, up 2.9%, driven by aftermarket strength and life sciences growth despite impairments. Segments showed resilience in mobile and industrial, with strategic acquisitions enhancing bioprocessing innovation amid global risks.
Story snapshot
CompanyDonaldson Company, Inc.
TickerDCI
VariantStandard detailed
Duration11:43
Filing type10-K
PeriodAnnual 2025
IndustryIndustrials & Manufacturing
Accession0000029644-25-000098
Full Story Script
Content not available for this story.